US Stock MarketDetailed Quotes

AX Axos Financial

Watchlist
  • 64.210
  • +0.480+0.75%
Close Mar 21 16:00 ET
  • 64.037
  • -0.173-0.27%
Post 18:15 ET
3.67BMarket Cap8.68P/E (TTM)

Axos Financial Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Axos Financial Q2 2025 Earnings Date

Currency：USDJan 28, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
302.16M
303.60M
+1.44M
Beat Est.
-14.34%
+19.34%
+0.48%
EPS
1.74
1.80
+0.06
Beat Est.
-33.65%
-31.30%
+3.55%
Analyst Rating
Strong Buy

Feb 28, 2025

Axos Financial Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 311.766M--
--2025/Q3-- / 305.044M--
Jan 28, 20252025/Q2307.898M / 302.161M--
Oct 30, 20242025/Q1320.657M / 298.632M--
Jul 30, 20242024/Q4290.923M / 297.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 311.766M--
--2025/Q3-- / 305.044M--
Jan 28, 20252025/Q2307.898M / 302.161M--
Oct 30, 20242025/Q1320.657M / 298.632M--
Jul 30, 20242024/Q4290.923M / 297.000M--

Unlock Free Earnings Estimates

Axos Financial Earnings Reports

  • Axos Financial | 10-Q: Q2 2025 Earnings Report

    Jan 28 16:15 ET

  • Axos Financial | 8-K: Axos Financial, Inc. Reports Second Quarter Fiscal Year 2025 Results

    Jan 28 16:12 ET

  • Axos Financial | 10-Q: Q1 2025 Earnings Report

    Oct 30, 2024 16:24 ET

  • Axos Financial | 8-K: Axos Financial, Inc. Reports First Quarter Fiscal Year 2025 Results

    Oct 30, 2024 16:13 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +14.85%
    New Fortress Energy
    NFE
    +7.92%
    Cars.com
    CARS
    +2.11%
    Halozyme Therapeutics
    HALO
    +1.31%
    Collegium Pharmaceutical
    COLL
    +0.40%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data